Heike Rockmann

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications

Angioedema in Primary Care: Disease Course and Its Relation to ACE Inhibitor Use.

Angioedema in Primary Care: Disease Course and Its Relation to ACE Inhibitor Use.

Journal: International journal of dermatology
Published: January 22, 2026

Performance of omalizumab in patients with mast cell-mediated angioedema with and without wheals.

Performance of omalizumab in patients with mast cell-mediated angioedema with and without wheals.

Journal: The journal of allergy and clinical immunology. In practice
Published: November 06, 2025

Current treatment practices and efficacy in solar urticaria: insights from a patient survey.

Current treatment practices and efficacy in solar urticaria: insights from a patient survey.

Journal: Frontiers in immunology
Published: August 11, 2025

Multi-omics profiling of chronic immune-mediated skin diseases: SKINERGY protocol and strategic evaluation.

Multi-omics profiling of chronic immune-mediated skin diseases: SKINERGY protocol and strategic evaluation.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 30, 2025

Exploring the Disease Duration of Urticaria and Associated Determinants in Primary Care.

Exploring the Disease Duration of Urticaria and Associated Determinants in Primary Care.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: June 19, 2025

Management of Chronic Spontaneous Urticaria Made Practical: What Every Clinician Should Know.

Management of Chronic Spontaneous Urticaria Made Practical: What Every Clinician Should Know.

Journal: The journal of allergy and clinical immunology. In practice
Published: May 06, 2025

Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long-Term Multicentre Real-World Study.

Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long-Term Multicentre Real-World Study.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: January 24, 2025

Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation.

Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation.

Journal: JAMA dermatology
Published: July 17, 2024

Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE study.

Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE study.

Journal: Allergy
Published: May 17, 2024

Performance of high-dose omalizumab in chronic urticaria is predicted by initial improvement to standard dose.

Performance of high-dose omalizumab in chronic urticaria is predicted by initial improvement to standard dose.

Journal: The journal of allergy and clinical immunology. In practice
Published: November 24, 2023

Prevalence of chronic urticaria and healthcare usage of patients with the condition in primary care: a population-based study in the Netherlands.

Prevalence of chronic urticaria and healthcare usage of patients with the condition in primary care: a population-based study in the Netherlands.

Journal: The British journal of dermatology
Published: August 14, 2023

Age and fast initial response predict omalizumab retreatment in chronic urticaria.

Age and fast initial response predict omalizumab retreatment in chronic urticaria.

Journal: The journal of allergy and clinical immunology. In practice
Published: April 01, 2023
Showing 1-12 of 40

Last Updated: 09/26/2026